Number,

Medicine, 

Longevity.

We build precise AI disease models to make high-accuracy predictions of clinical trial outcomes for all diseases.

Sign up now to receive our performance update!

Demiurge has achieved 88.5% (77/87) accuracy in our prospective predictions of phase 2 and phase 3 clinical trial results in 2020.

88.5%

PREDICTION ACCURACY RATE

as of 31 December 2020  

for all therapeutic areas excluding genetic disorders and hematological disorders. 

Picture%201_edited.jpg

85.7%

PREDICTION ACCURACY RATE

Even for new diseases like COVID-19 without any preexisting clinical data, Demiurge published a detailed COVID-19 disease model in March 2020 (Lovetrue, 2020 here) and has achieved 85.7% accuracy (18/21) in prospective predictions of phase 2 and phase 3 COVID-19 clinical trial results in 2020.

as of 31 December 2020

2_edited.jpg

+43.5%

Demiurge's prediction accuracy has beaten the weighted benchmark by a wide margin of +43.5%.   

as of 31 December 2020

Demiurge
Weighted
Benchmark
45%
88.5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Prediction Accuracy

INDICATIONS

131

26

THERAPEUTIC ARES

Demiurge has made 280+ perspective predictions 
covering 131
 indications in 26 therapeutic areas

as of 31 December 2020

3_edited.png
logo front page.png